At present, the laboratory diagnosis of syphilis is based on the visualisation of the pathogen, Treponema pallidum and/or the demonstration of specific antibodies in body fluids by means of serological tests. In this article the current methods, the test procedures that have only recently been introduced to diagnose syphilis and the diagnosis based on molecular biology techniques are reviewed.
Introduction
At present, the laboratory diagnosis of syphilis is based on the visualisation of the pathogen, Treponema pallidum and/or the demonstration of specific antibodies in body fluids by means of serological tests. In this article the current methods, the test procedures that have only recently been introduced to diagnose syphilis and the diagnosis based on molecular biology techniques are reviewed.
Visualisation of the pathogen The diagnosis of syphilis by direct visualisation of the causative organism is complicated, since at present T pallidum cannot be routinely cultivated in vitro on artificial media.' Treponemes can be observed in exudates of primary and secondary lesions and in fluid obtained from lymph node puncture upon dark-field microscopy. 2 Recently, darkfield examination of amniotic fluid obtained by amniocentesis has been shown to be valuable in the diagnosis of congenital syphilis.3 The treponemes are recognised by their characteristic morphology and motility. The preparations should be examined with minimal delay because of the poor retention of motility of the treponemes in vitro. The direct or indirect fluorescent method is a suitable alternative if direct dark-field microscopy is not possible.5`7The visualisation of T pallidum by either method is diagnostic, provided that non-venereal treponematoses are excluded.
Rabbit infectivity testing (RIT) for routine diagnostic purposes with materials from suspected patients is impractical since the development of orchitis and/or seroconversion in the rabbit takes rather long and appropriate facilities to house and handle the rabbits are necessary. However, RIT is the only test available to demonstrate the presence of virulent treponemes.8
Histochemistry and Immunohistochemistry Treponemes can be observed in formalin-fixed and paraffin embedded biopsy material using silver impregnation methods such as theWhartin-Starry9 or the Steiner method."`Immunological recognition of T pallidum in paraffin embedded tissues has been described. 56 '9 In the 19S(IgM)FTA-ABS test, the 19S (=IgM containing) fraction from the test sera is used to avoid false-positive reactions caused by rheumatoid factor (Rf).0 However, the FTA-ABS test is technically complicated and requires continuous quality control checks in order to obtain reliable and reproducible results. Moreover, each test result has to be read individually by an experienced observer. This excludes automation and processing of large numbers of sera and may introduce subjectivity in interpreting the results.
Treponemal tests are performed qualitatively. Once positive, the test results usually remain so for many years and often lifelong. Hence these tests are not suitable for monitoring the effect of treatment.
Shortcomings of the present tests are their insufficient sensitivity and/or specificity in the diagnosis of incubating primary syphilis, congenital syphilis and neurosyphilis and their inability to distinguish between venereal and nonvenereal treponematoses. Moreover, since co-infections with human immunodeficiency virus (HIV) can change the outcome of serological test for syphilis, methods that can detect (parts of) the syphilis pathogen are desirable. From a technical and economic point of view, automated tests which would be suitable for screening, confirmation purposes and treatment monitoring would be welcome.
Application of ELISA The enzyme-linked immunosorbent assays (ELISA) are widely used in the field of infectious diseases owing to the possibility of automation and the broad potential to detect antibodies, antigens and haptens (for a recent review see ref 21) . After the first use of the indirect ELISA in the serodiagnosis of syphilis,22 several related tests in which detergent extracted or sonicated T pallidum (Nichols) were used as an antigen have been reported. 23 24 (87.5%) sera of patients with untreated primary syphilis, all FTA-ABS positive, were also positive in the TmpA-ELISA. The sera from patients with untreated secondary syphilis (n = 25) and latent syphilis (n = 19) reacted positively in the TmpA and were also positive in FTA-ABS, TPHA and VDRL tests. Sera from patients with treated syphilis were divided into groups with a positive VDRL (n = 30) and a negative VDRL (n = 30). In the VDRL-reactive group, 25 sera were positive in the TmpA-ELISA, while in the VDRL-nonreactive group, 10 sera were positive. The authors observed a correlation between the VDRL-titre and the presence of anti-TmpA antibodies and suggested that in addition to screening, the TmpA-ELISA would also be useful for monitoring the effect of therapy. This suggestion was investigated by IJsselmuiden et al. 49 In this study the TmpA-ELISA had a sensitivity of 76% (42/55) in untreated primary syphilis, a sensitivity of 100% in secondary and of 98% in early latent syphilis. The lower sensitivity in primary syphilis in this study was due to the incorporation of dark-field positive but FTA-ABS negative patients. In treated VDRL-reactive syphilis patients, the TmpA-ELISA had a sensitivity of 85% and in VDRL-nonreactive syphilis patients a sensitivity of 37%. In a group of 27 patients with VDRL-reactive syphilis, it was shown that in the sera from 25 patients with early syphilis, the kinetics of the decline in antiTmpA antibodies paralleled the decline in anti-cardiolipin antibodies in response to therapy. The two exceptions were the sera from a patient with late latent syphilis and from a patient with asymptomatic neurosyphilis. The authors recommended the TmpA-ELISA assay (commercially available from EuroDiagnostics, Apeldoorn, The Netherlands) as a screening test which would also be suitable for treatment-monitoring.
Application of PCR technique to the diagnosis of syphilis
The polymerase chain reaction has been used by Hay et a050 ' to detect DNA sequences specific for pathogenic treponemes in cerebrospinal fluid (CSF). Sequences of 519 and 428 base pairs (bp) from the TmpA and 4D genes respectively were amplified. Using the method, it was possible to detect 65 organisms in 0.5 nil CSF as determined by diluting suspensions of Nichols treponemes. The specificity using 30 CSF specimens from individuals not suspected of HIV infection or syphilis was at least 96.7%. From the 19 CSF specimens examined for latent or tertiary syphilis, 10 (53%) were positive. Twenty-eight specimens obtained from HIV-positive patients, of whom 14 had "CNS disease" were tested for the presence of treponemal DNA. Seven patients from the CNS disease group were positive. From the remaining seven patients in the CNS disease group and from the 14 patients without CNS disease, three and five patients respectively had a history of syphilis. None of these 21 patients were positive using the PCR technique. Noordhoek et al52 used PCR to detect trepsnemal DNA in CSFs from 27 patients with untreated symptomatic and asymptomatic neurosyphilis. The gene for the 39 kDa basic membrane protein was chosen for amplification. This was performed in two parts. In the first part the primers allowed the amplification of a 617 bp fragment, in the second part a second primer set (nested primers) allowed amplification of a 500 bp fragment from the previously amplified 617 bp fragment. With this PCR method, it was possible to detect that amount of isolated treponemal DNA which was equivalent to a single treponeme and a minimum of 100 treponemes per ml when suspended in CSF. Specificity was assessed using a large variety of microorganisms including Borrelia burgdorferi. Specific amplification was only noted with DNA from Tpallidum ssp pallidum and pertenue. Positive results were obtained with CSFs from five out of seven patients with acute neurosyphilis. None of the four patients with chronic neurosyphilis but two out of 16 patients with asymptomatic neurosyphilis were positive. However, CSFs obtained up to three years after treatment were frequently positive using PCR. This was rather puzzling since none of the patients showed evidence of active disease following treatment and the titres in the serological tests declined slowly.
Burstein et al53 amplified a 658 bp portion of the gene coding for the 47 kDa membrane protein. The probe used to detect the amplified DNA by hybridisation consisted of a large 496 bp fragment included in the amplified DNA. Using this method, the authors were able to detect treponemal DNA in some samples calculated to contain a single treponeme. Special attention was paid to DNA that could possibly contaminate clinical isolates. No specific amplification products were obtained from any of the tested skin microbes, central nervous system pathogens and microbes causing STD. Specific amplification occurred only with the DNA from T pallidum ssp pertenue. Positive PCR results, confirmed by RIT were obtained with the amniotic fluid from the two pregnant women with untreated syphilis, with the serum and the CSF from the patient with untreated early latent syphilis, but whose CSF showed normal clinical laboratory tests and with the CSF from the patient with syphilitic meningitis. The CSFs from two patients with general paresis were negative.
The study by Grimprel et al54 focused on the inhibition of PCR by contaminants in clinical samples to optimise the method for the diagnosis of congenital syphilis. This inhibition was noted in a previous report, especially when larger volumes were used for amplification. 53 Four different methods were used to prepare DNA prior to amplification: a boiling method, a low spin centrifugation method, the alkaline lysis extraction method and a spin extraction method. The authors suggested that preparation of DNA from amniotic fluids should be performed by the boiling and the low spin centrifugation method. For neonatal CSF and sera the simple boiling method should be initially used with 10 and 20lul volumes and if necessary, followed by the low spin centrifugation method. The method showed a specificity of 100% indicating that false-positive results due to contamination of the samples during collection and processing had not occurred. The sensitivity of the PCR, as compared with RIT was 100% for amniotic fluids, 71% for neonatal CSFs and 68% for sera. An interesting aspect was the detection of an in utero treatment failure. Used in this manner, the PCR technique would be useful to establish optimal treatment schedules for congenital syphilis.
Attempts to distinguish sub-species of T pallidum Recombinant DNA studies showed a single base pair difference between the genes tpf-1 and tyf-l which code for homologous sub-units of the' 190 kDa proteins of T pallidum ssp pallidum and ssp pertenue respectively.55 This difference was exploited in attempts to distinguish between DNA extracted from rabbit derived Tpallidum ssp pallidum and ssp pertenue after amplification using the PCR technique. DNA from three of the four T pallidum ssp pallidum strains contained the "pallidum" trait. In five out of the six strains of Tpallidum ssp pertenue the "pertenue" trait was present. This indicated that the observed difference between the tpf-1 and tyf-1 genes did not constitute a definite trait for either T pallidum sub-species.56 The 
